Development of taste masked oral formulation of ornidazole

Indian Journal of Pharmaceutical Sciences

Volumn 72, Issue 2, 2010, Pages 211-215

  Shishu, ^a   Kamalpreet, ^a   Kapoor, V R ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Eudragit E 100; fast disintegrating tablets; microspheres; ornidazole; taste masking

Indexed keywords

DISINTEGRATING AGENT; MICROCRYSTALLINE CELLULOSE; MICROSPHERE; ORNIDAZOLE; STARCH GLYCOLATE SODIUM;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG SCREENING; FILTER; HUMAN; HUMAN EXPERIMENT; MOUTH CAVITY; NORMAL HUMAN; SENSORY NERVE; SPECTROPHOTOMETRY; TABLET DISINTEGRATION; TABLET FORMULATION; TASTE; TASTE ACUITY;

EID: 77954841912     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.65018     Document Type: Article

References (16)

1. Fu Y, Yang S, Jeong SH, Kimura S, Park K. Orally fast disintegrating tablets: Developments, technologies, taste-masking and clinical studies. Crit Rev Ther Drug Carrier Syst 2004;21:433-476
2. Shishu, Bhatti A. Fast disintegrating tablets of diazepam. Indian Drugs 2006;43:643-648
3. Douroumis D. Practical approaches of taste masking technologies in oral solid forms. Expert Opin Drug Deliv 2007;4:417-426
4. Suzuki H, Onishi H, Takahashi Y, Iwata M, Machida Y. Development of oral acetaminophen chewable tablets with inhibited bitter taste. Int J Pharm 2003;251:123-132
5. Sohi H, Sultana Y, Khar RK. Taste masking technologies in oral pharmaceuticals: Recent developments and approaches. Drug Dev Ind Pharm 2004;30:429-448
6. Mizumotoa T, Masuda Y, Yamamoto T, Yonemochi E, Terada K. Formulation design of a novel fast-disintegrating tablet. Int J Pharm 2005;306:83-90.
7. Lorenzo-Lamosa ML, Cuna M, Vila-Jato JL, Torres D, Alonso MJ. Development of a microencapsulated form of cefuroxime axetil using pH-sensitive acrylic polymers. J Microencapsul 1997;14:607-616
8. Shirai Y, Sogo K, Yamamoto K, Kojima K, Fujioka H, Makita H et al. A novel fine granule system for masking bitter taste. Biol Pharm Bull 1993;16:172-177
9. Sjoqvist R, Graffner C, Ekman I, Sinclair W, Woods JP. In vivo validation of the release rate and palatability of remoxipride-modified release suspension. Pharm Res 1993;10:1020-1026
10. Goodhart FW, Draper JR, Dancz D, Ninger FC. Evaluation of tablet breaking strength testers. J Pharm Sci 1973;62:297-304.
11. Banker GS, Anderson NR. Tablets. In: Lachman L, Lieberman HA, Kanig JL, editors. The Theory and Practice of Industrial Pharmacy. 3rd ed. Philadelphia: Lea and Febiger; 1991. p. 293345.
12. Bi Y, Sunada H, Yonezawa Y, Danjo K, Otsuka A, Iida K. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem Pharm Bull (Tokyo) 1996;44:2121-2127
13. Siewert M, Dressman J, Brown C, Shah V. FIP/AAPS Guidelines for Dissolution/In Vitro Release Testing of Novel/Special Dosage Forms. Dissolution Technologies. The American Association of Pharmaceutical Scientists (AAPS, US); 2003. p. 6-15.
14. Bartoshuk LM. Bitter taste of saccharin related to the genetic ability to taste the bitter substance 6-n-propylthiouracil. Science 1979;205:934-935
15. Murakami T, Aritomi H, Ueno N. Quickly disintegratable compression-molded materials and process for producing the same. US Patent No 6 287 596; 2001.
16. Khankari RK, Hontz J, Chastain SJ, Katzner L. Rapidly dissolving robust dosage form. US Patent No 6 024 981; 2001.